Skip to main content

My Watchlist for Thursday, May 04

( click to enlarge )
New York Times Co (NYSE:NYT) looks ready to make new highs. On the technical side, the daily chart looks very good. The MACD is positive and above its rising signal line. The 50-day and 200-day EMAs are both rising with the stock trading above them. Breakout watch over 16.3

( click to enlarge )
USANA Health Sciences, Inc. (NYSE:USNA) is again setting up for a potential swing trade. Breakout watch over 60.

( click to enlarge )
Rosetta Genomics Ltd. (NASDAQ:ROSG) Thin name. Looks like the stock wants to break this downtrend trend line. On watch tomorrow.

( click to enlarge )
Twitter Inc (NYSE:TWTR) The stock continues to act well above the EMA200. Next buy area when clears 18.77 on heavy volume.

( click to enlarge )
Pieris Pharmaceuticals Inc (NASDAQ:PIRS) Good breakout on high volume. Buyable on a pullback to the pivot.

( click to enlarge )
ContraVir Pharmaceuticals Inc (NASDAQ:CTRV) continues to close above the 80c level with the daily chart showing still extreme oversold readings. It seems to me the recent dips have been bought. The accumulation line is also displaying a positive divergence. Technically, a bounce looks imminent.

If you want to contact me for advertising opportunities on blog or twitter, then get in touch via email

Disclaimer : This is not an investment advisory, and should not be used to make investment decisions. Information in AC Investor Blog is often opinionated and should be considered for information purposes only. No stock exchange anywhere has approved or disapproved of the information contained herein. There is no express or implied solicitation to buy or sell securities. The charts provided here are not meant for investment purposes and only serve as technical examples. Don't consider buying or selling any stock without conducting your own due diligence.

Thanks for visiting AC Investor Blog.

AC
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.